Virtualman offers an AI-Driven Drug Development (ADDD) platform aimed at optimizing the drug development process. Backed by profound expertise in pharmaceutics and AI technologies, the platform expedites the optimization of various drug parameters, producing tailored models within a few weeks. With features like automatic multi-parameter optimization and in-vitro and in-vivo testing managed by AI and expert scientists, it ensures robust and reliable outcomes. The solution presently boasts achievements like over 1161 compounds with low toxicity and high bioavailability. Additional services include ICH M7 impurities assessment with QSAR models and expert reviews for registration purposes.